1. ALLA AKTIER
  2. NYHETER
  3. PMD DEVICE SOLUTIONS

PMD Device Solutions

Nyheter PMD Device Solutions Nyheter alla bolag

Update to closure date for the Transfer Agreement between PMD Device Solutions and Coala-Life Group AB

PMDS and the Trustee of Coala-Life Group AB Estate will extend the closing date to April 12th.

PMDS and the Trustee of Coala-Life Group AB Estate continue to finalise key specifications of the assets before signing the Transfer Agreement. The agreement is anticipated to be signed on April 11th.

For additional information, please contact

Myles Murray, CEO
Phone: +353 86 887 4994
E-mail: myles@pmd-solutions.com & for general enquiries investor.relations@pmd-solutions.com 
The Company’s Certified Adviser is Redeye.

Information about PMDS

PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company’s knowledge, the world’s only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA cleared in the US. The company’s shares are listed on Nasdaq First North Growth Market (STO: PMDS).

Attachments

Update to closure date for the Transfer Agreement between PMD Device Solutions and Coala-Life Group AB

Datum 2024-04-11, kl 08:30
Källa MFN
Bifogade filer
Update to closure date for the Transfer Agreement between PMD Device Solutions and Coala-Life Group AB
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!